Kayo Asada

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.

Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.

Journal: Scientific reports

Published: August 12, 2023

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma.

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma.

Journal: Journal for immunotherapy of cancer

Published: April 07, 2020

Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report.

Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report.

Journal: Molecular and clinical oncology

Published: June 30, 2019

Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.

Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.

Journal: Biochemical and biophysical research communications

Published: March 13, 2019

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.

Journal: BMC cancer

Published: October 12, 2018

The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.

The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.

Journal: Oncoimmunology

Published: April 12, 2017

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

Journal: Oncotarget

Published: May 14, 2016

Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies.

Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies.

Journal: The journal of obstetrics and gynaecology research

Published: January 28, 2016

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.

Journal: PloS one

Published: July 07, 2015

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.

Journal: PloS one

Published: September 03, 2014

Poor prognosis of ovarian cancer with large cell neuroendocrine carcinoma: case report and review of published works.

Poor prognosis of ovarian cancer with large cell neuroendocrine carcinoma: case report and review of published works.

Journal: The journal of obstetrics and gynaecology research

Published: April 17, 2014

Laparoscopic ovarian-sparing surgery for a young woman with an exophytic ovarian fibroma.

Laparoscopic ovarian-sparing surgery for a young woman with an exophytic ovarian fibroma.

Journal: The journal of obstetrics and gynaecology research

Published: November 25, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026